SION (STOCKS)
Sionna Therapeutics, Inc. Common Stock
$6.500000
+0.250000 (+4.00%)
Prev close: $6.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Cloonan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $295.24M
- Employees
- 48
- P/E (TTM)
- -3.02
- P/B (TTM)
- 1.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
7
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.66 | $-0.66 | +0.0025 | +0.38% |
|
Mar 2026 (Q1)
|
$-0.60 | $-0.52 | -0.0756 | -14.42% |
|
Dec 2025 (Q4)
|
$-0.46 | $-0.55 | +0.0894 | +16.27% |
|
Sep 2025 (Q3)
|
$-0.46 | $-0.49 | +0.0340 | +6.88% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $12.10M |
| Operating Expenses | $109.49M |
| Research and Development | $72.04M |
| Other Operating Expenses | $37.45M |
| Operating Income/Loss | -$109.49M |
| Income/Loss From Continuing Operations After Tax | -$97.38M |
| Income/Loss From Continuing Operations Before Tax | -$97.38M |
| Net Income/Loss | -$97.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$97.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$97.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.16 |
| Diluted Earnings Per Share | -$2.16 |
| Basic Average Shares | 91,135,933 |
| Diluted Average Shares | 91,135,933 |
| Assets | $283.25M |
| Current Assets | $216.13M |
| Cash | $268.30M |
| Noncurrent Assets | $67.12M |
| Fixed Assets | $1.92M |
| Other Non-current Assets | $65.20M |
| Liabilities | $17.47M |
| Current Liabilities | $10.78M |
| Wages | $2.78M |
| Other Current Liabilities | $8.01M |
| Noncurrent Liabilities | $6.69M |
| Equity | $265.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $265.78M |
| Liabilities And Equity | $283.25M |
| Net Cash Flow From Operating Activities | -$75.92M |
| Net Cash Flow From Operating Activities, Continuing | -$75.92M |
| Net Cash Flow From Investing Activities | $91.98M |
| Net Cash Flow From Investing Activities, Continuing | $91.98M |
| Net Cash Flow From Financing Activities | $6.28M |
| Net Cash Flow From Financing Activities, Continuing | $6.28M |
| Net Cash Flow | $22.34M |
| Net Cash Flow, Continuing | $22.34M |
| Comprehensive Income/Loss | -$98.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$98.01M |
| Other Comprehensive Income/Loss | -$2.47M |
| Other Comprehensive Income/Loss Attributable To Parent | -$631.00K |